Becton Dickinson and Company

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:public_company
gptkbp:acquiredBy	gptkb:CareFusion_(2015) C. R. Bard (2017)
gptkbp:alsoKnownAs	gptkb:BD
gptkbp:annualReport	https://investors.bd.com/financials/annual-reports/default.aspx
gptkbp:CEO	gptkb:Tom_Polen
gptkbp:countryOfOrigin	gptkb:United_States
gptkbp:division	gptkb:BD_Interventional gptkb:BD_Life_Sciences gptkb:BD_Medical
gptkbp:founded	1897
gptkbp:foundedIn	gptkb:New_York_City,_United_States
gptkbp:founder	gptkb:Fairleigh_Dickinson gptkb:Maxwell_Becton
gptkbp:headquartersLocation	gptkb:Franklin_Lakes,_New_Jersey,_United_States
gptkbp:industry	gptkb:medical_device
gptkbp:ISIN	US0758871091
gptkbp:logo	BD logo.svg
gptkbp:marketCap	over $70 billion (2023)
gptkbp:memberState	over 190
gptkbp:mission	Advancing the world of health
gptkbp:netIncome	$1.1 billion (2023)
gptkbp:notableProduct	needles biosciences instruments infusion therapy devices syringes
gptkbp:numberOfEmployees	~77,000
gptkbp:products	gptkb:research_institute medical devices diagnostic products
gptkbp:revenue	$18.87 billion (2023)
gptkbp:stockExchange	gptkb:S&P_500
gptkbp:stockSymbol	gptkb:BDX
gptkbp:subsidiary	gptkb:C._R._Bard gptkb:CareFusion
gptkbp:tradedOn	gptkb:NYSE:_BDX
gptkbp:website	https://www.bd.com
gptkbp:bfsParent	gptkb:BDG
gptkbp:bfsLayer	7
https://www.w3.org/2000/01/rdf-schema#label	Becton Dickinson and Company